Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault.
about
AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progressionSmall carboxyl-terminal domain phosphatase 2 attenuates androgen-dependent transcriptionNew insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancerGenome-wide impact of androgen receptor trapped clone-27 loss on androgen-regulated transcription in prostate cancer cellsAcquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic HyperplasiaHuman Prostate Cancer Hallmarks MapA peptide against soluble guanylyl cyclase α1: a new approach to treating prostate cancerThe importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applicationsCaveolae contribute to the apoptosis resistance induced by the alpha(1A)-adrenoceptor in androgen-independent prostate cancer cellsCXCR4 expression in prostate cancer progenitor cellsA role for the androgen-receptor in clinically localized and advanced prostate cancer.New developments in the medical management of prostate cancer.COP9 subunits 4 and 5 target soluble guanylyl cyclase α1 and p53 in prostate cancer cells.Therapeutic value of quinazoline-based compounds in prostate cancer.Curcumin Inhibits Prostate Cancer Bone Metastasis by Up-Regulating Bone Morphogenic Protein-7 in VivoDiosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expressionDominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer.5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.Stromal androgen receptor in prostate development and cancer.Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.Spontaneous cancer-stromal cell fusion as a mechanism of prostate cancer androgen-independent progressionAndrogen receptor signaling and mutations in prostate cancerSomatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy.Morusin induces cell death through inactivating STAT3 signaling in prostate cancer cellsCombinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer.STAMP2 increases oxidative stress and is critical for prostate cancer.Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors.Mechanisms of acquired androgen independence during arsenic-induced malignant transformation of human prostate epithelial cells.Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer.Epidermal growth factor, neurotrophins and the metastatic cascade in prostate cancer.The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: Androgen-receptor cofactors and bypass pathways.TRPM8 channel as a novel molecular target in androgen-regulated prostate cancer cells.The androgen receptor and mechanisms for androgen independence in prostate cancer.Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistanceNew strategies for the medical treatment of prostate cancer.Synergistic activity of the mTOR inhibitor ridaforolimus and the antiandrogen bicalutamide in prostate cancer models.Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer.
P2860
Q21203668-8A8BD59C-C162-493A-A968-8ED4687B9C4AQ24337882-6C34FF25-41A8-49CC-AA0A-569B6850F6CDQ24619151-D162BBF7-B1B3-4841-B77B-9CCF65992C23Q24657502-B4785E37-414F-426C-A3F9-5C65D1003043Q24815477-570F62D9-2F0A-433F-8EBA-D634A93DF997Q26741226-DDC780FE-216B-4645-96A4-4EFBABB9F433Q26779590-C1F00B73-1735-4EFB-B604-9787917CEE71Q27319501-3B8DE75B-FB46-4841-98FB-F583463D220CQ28076745-381213B6-9B79-4550-A1A0-F32D9AC4AD6AQ28389539-9CC43454-3B11-46CB-88CE-6F1A609ED8C1Q28476183-94546AFB-53BF-4D59-A8DF-66DC99DA6F13Q28480904-660165ED-40AC-4FBD-B2DF-373F01D46CCEQ33561073-CC2E4598-0458-4A60-89F1-F8C595F05681Q33566738-3C41FBEF-BF64-4AB3-BBD7-E010A3BAD797Q33701401-F18751BF-5DEA-40EF-930C-E17F6ED0109EQ33746225-4F9820F0-E688-4DA5-A312-CC98A85F5A00Q33767832-8B3069FD-1055-4880-A367-11419C3C35FAQ33918409-1D177A18-F953-495C-9D0B-1BC71DEBDA6FQ34137546-074512EF-332C-45ED-B5E9-228F2F625B39Q34183936-E41FD212-E8C2-4E7E-882A-3EBCA870C6F3Q34302834-3E15F8EF-1722-48A1-8FE7-A5E096BFF8A7Q34330174-99B8BAF4-4271-481D-8285-C7C85B04E6E0Q34374537-CB567EDB-B003-4109-8255-E88590C19962Q34425907-671BE67B-FC98-4F72-BC26-532C413FA3D2Q34586300-19CC43BA-CD71-4C9C-89E9-643D1A0F1CDFQ34991240-F0D5AA5C-B1B6-4EBF-B549-3818CD136861Q35080706-EF98E4EC-78E4-4D13-954C-5F1107C32BF9Q35192455-B5C44D8C-6F83-463B-87B5-A9DAECC91652Q35647541-8CBE64D1-4AFC-46CD-95D2-D318F98BB732Q35672221-B30C72D8-9DD0-4A9F-8810-BC0137ED4B0BQ35740095-F25EAAB1-D400-4481-9D5B-20502D2EEC0FQ35806990-1B6AC1EC-D984-452A-BA72-E2A298D544B9Q35848658-920BCBA2-5B4E-4A79-A146-4E9BDD5BA2A3Q36126920-131C8E31-1C12-4293-BB33-7CD2AB4D751CQ36232009-EF0B3446-C224-4D7F-9C6A-E9D5F41AE478Q36276350-407C99A0-5861-4F4A-883B-822701C621FEQ36282200-08DA3F12-B2DA-4A11-ADFD-066FD851FE3FQ36344215-70021479-EC33-44A3-8602-D312463FCA65Q36640426-F7A7C760-F9F6-441F-888B-C0634CA55227Q37098796-E5923896-2DBD-44E9-8848-DC7DB7B2109E
P2860
Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mechanisms involved in the pro ...... only the cancer cell's fault.
@ast
Mechanisms involved in the pro ...... only the cancer cell's fault.
@en
Mechanisms involved in the pro ...... only the cancer cell's fault.
@nl
type
label
Mechanisms involved in the pro ...... only the cancer cell's fault.
@ast
Mechanisms involved in the pro ...... only the cancer cell's fault.
@en
Mechanisms involved in the pro ...... only the cancer cell's fault.
@nl
prefLabel
Mechanisms involved in the pro ...... only the cancer cell's fault.
@ast
Mechanisms involved in the pro ...... only the cancer cell's fault.
@en
Mechanisms involved in the pro ...... only the cancer cell's fault.
@nl
P2860
P356
P1476
Mechanisms involved in the pro ...... only the cancer cell's fault.
@en
P2093
J T Arnold
J T Isaacs
P2860
P356
10.1677/ERC.0.0090061
P577
2002-03-01T00:00:00Z